Tagged with immuno-oncology

Astellas’ Peter Sandor on the Future of Immuno-Oncology
Stephen Yoo – CEO & CSO, STCube Pharmaceuticals
Cătălin Radu – General Manager, Bristol Myers Squibb (BMS) Romania
Interview: Amy Huang – General Manager, OBI Pharma, Taiwan
Interview: Dominique Costantini – CEO, OSE Pharma, France
Interview: Michel Ginestet – Global Innovative Pharma (GIP) Business Unit Head and President, Pfizer France
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here